[go: up one dir, main page]

ATE345345T1 - Thieno(2,3-d)pyrimidine mit kombinierter lh und fsh agonistischen wirkung - Google Patents

Thieno(2,3-d)pyrimidine mit kombinierter lh und fsh agonistischen wirkung

Info

Publication number
ATE345345T1
ATE345345T1 AT02772230T AT02772230T ATE345345T1 AT E345345 T1 ATE345345 T1 AT E345345T1 AT 02772230 T AT02772230 T AT 02772230T AT 02772230 T AT02772230 T AT 02772230T AT E345345 T1 ATE345345 T1 AT E345345T1
Authority
AT
Austria
Prior art keywords
thieno
pyrimidines
combined
agonistic effects
fsh agonistic
Prior art date
Application number
AT02772230T
Other languages
English (en)
Inventor
Robert Gerard Jules Ma Hanssen
Cornelis Marius Timmers
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Application granted granted Critical
Publication of ATE345345T1 publication Critical patent/ATE345345T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT02772230T 2001-09-04 2002-08-29 Thieno(2,3-d)pyrimidine mit kombinierter lh und fsh agonistischen wirkung ATE345345T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01203327 2001-09-04

Publications (1)

Publication Number Publication Date
ATE345345T1 true ATE345345T1 (de) 2006-12-15

Family

ID=8180876

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02772230T ATE345345T1 (de) 2001-09-04 2002-08-29 Thieno(2,3-d)pyrimidine mit kombinierter lh und fsh agonistischen wirkung

Country Status (28)

Country Link
US (1) US7317006B2 (de)
EP (1) EP1427733B1 (de)
JP (1) JP4262092B2 (de)
KR (1) KR100900018B1 (de)
CN (1) CN1246324C (de)
AR (1) AR036407A1 (de)
AT (1) ATE345345T1 (de)
AU (1) AU2002337035B2 (de)
BR (1) BR0211938A (de)
CA (1) CA2456901C (de)
CY (1) CY1106012T1 (de)
DE (1) DE60216128T2 (de)
DK (1) DK1427733T3 (de)
ES (1) ES2275005T3 (de)
HR (1) HRP20040202A2 (de)
HU (1) HUP0401444A3 (de)
IL (1) IL160084A0 (de)
IS (1) IS2424B (de)
MX (1) MXPA04002045A (de)
NO (1) NO20040927L (de)
NZ (1) NZ531340A (de)
PE (1) PE20030439A1 (de)
PL (1) PL368502A1 (de)
PT (1) PT1427733E (de)
RU (1) RU2298011C2 (de)
TW (1) TWI228508B (de)
WO (1) WO2003020726A1 (de)
ZA (1) ZA200401455B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890923B2 (en) * 2002-12-16 2005-05-10 Astrazeneca Ab Compounds
GB0315950D0 (en) * 2003-06-11 2003-08-13 Xention Discovery Ltd Compounds
GB0525164D0 (en) * 2005-12-09 2006-01-18 Xention Discovery Ltd Compounds
CN100430403C (zh) * 2006-10-13 2008-11-05 中国科学院上海有机化学研究所 3-芳基-5,6-取代噻吩并嘧啶-4-羰基-2-巯基乙腈、合成方法和用途
US20090118276A1 (en) * 2007-11-02 2009-05-07 Wyeth Thienopyrimidines, thienopyridines, and pyrrolopyrimidines as b-raf inhibitors
TWI389913B (zh) * 2008-09-08 2013-03-21 Lg Life Sciences Ltd 并合雜環化合物
WO2010047674A1 (en) 2008-10-20 2010-04-29 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Low molecular weight thyroid stimulating hormone receptor (tshr) agonists
GB0905525D0 (en) 2009-03-31 2009-05-13 Univ Leiden Compounds and uses
EA022553B1 (ru) 2010-01-22 2016-01-29 Байер Интеллектуэль Проперти Гмбх Применение комбинации биологически активных веществ, набор и средство, содержащие комбинацию биологически активных веществ, для борьбы с вредителями животного происхождения и способ улучшения использования продукционного потенциала трансгенного растения
EP2563777A4 (de) 2010-04-08 2013-09-04 Us Health Inverse agonisten und neutrale agonisten für den tsh-rezeptor
RU2619091C2 (ru) * 2015-10-13 2017-05-11 Министерство Промышленности И Торговли Рф Цилиндрический термоэмиссионный катод
AU2023282849A1 (en) * 2022-06-08 2025-01-09 Icahn School Of Medicine At Mount Sinai Method of treating obesity with a luteinizing hormone receptor agonist

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3879031T2 (de) 1987-08-08 1993-06-24 Akzo Nv Kontrazeptives implantat.
TW564247B (en) * 1999-04-08 2003-12-01 Akzo Nobel Nv Bicyclic heteraromatic compound

Also Published As

Publication number Publication date
EP1427733B1 (de) 2006-11-15
IS7130A (is) 2004-01-29
CA2456901C (en) 2011-01-04
AR036407A1 (es) 2004-09-08
PE20030439A1 (es) 2003-05-17
WO2003020726A1 (en) 2003-03-13
PL368502A1 (en) 2005-04-04
HRP20040202A2 (en) 2004-08-31
JP2005505555A (ja) 2005-02-24
JP4262092B2 (ja) 2009-05-13
CY1106012T1 (el) 2011-04-06
RU2004110042A (ru) 2005-08-20
ZA200401455B (en) 2004-11-19
KR100900018B1 (ko) 2009-06-01
CN1246324C (zh) 2006-03-22
AU2002337035B2 (en) 2008-04-24
NZ531340A (en) 2005-08-26
US7317006B2 (en) 2008-01-08
ES2275005T3 (es) 2007-06-01
DE60216128D1 (de) 2006-12-28
RU2298011C2 (ru) 2007-04-27
HUP0401444A3 (en) 2008-05-28
IS2424B (is) 2008-10-15
PT1427733E (pt) 2007-02-28
DE60216128T2 (de) 2007-09-27
DK1427733T3 (da) 2007-03-19
NO20040927L (no) 2004-03-03
CA2456901A1 (en) 2003-03-13
MXPA04002045A (es) 2004-07-08
KR20040029134A (ko) 2004-04-03
BR0211938A (pt) 2004-09-21
TWI228508B (en) 2005-03-01
US20040180873A1 (en) 2004-09-16
HUP0401444A2 (hu) 2004-11-29
IL160084A0 (en) 2004-06-20
CN1551884A (zh) 2004-12-01
EP1427733A1 (de) 2004-06-16

Similar Documents

Publication Publication Date Title
EP1401840A4 (de) Neue 4-amino-5,6-substituierte thiopheno 2,3 d|pyrimidine
NO20034929L (no) 4-amino-5-fenyl-7-cyklobutylpyrrol(2,3-D)pyrimidinderivater
ATE388713T1 (de) 4-amino-6-phenyl-pyrrolo(2,3-d)pyrimidin derivate
NO20042676L (no) 3-beta-d-ribofuranolsyltiazolo[4,5-d]pyrimidinnukleosider og anvendelser derav
NO20022738L (no) Pyrrolo(2,3-d)pyrimidinforbindelser
ATE284872T1 (de) 4,5-dihydro-1h-pyrazolderivate mit cb1- antagonistischer wirkung
DZ3308A1 (de) 5-alkylpyrido [2,3-d] pyrimidin tyrosine kinase inhibitoren
ATE387446T1 (de) Pyrido(2,3-d)pyrimidin-2,4-diamine als pde-2- inhibitoren
HK1087108A1 (en) 5,7-diaminopyrazolo[4,3-d] pyrimidines useful in the treatment of hypertension
ATE345345T1 (de) Thieno(2,3-d)pyrimidine mit kombinierter lh und fsh agonistischen wirkung
HUP0401684A3 (en) Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides
DE60205921D1 (de) SUBSTITUIERTE 2-PYRIDINYL-6,7,8,9-TETRAHYDROPYRIMIDOç1,2-A!PYRIMIDIN-4-ON- UND 7-PYRIDINYL-2,3-DIHYDROIMIDAZO-ç1,2-A!PYRIMIDIN-5(1H)ONDERIVATE
ATE231866T1 (de) Pyrazolo(4, 3-d)pyrimidine
ATE309251T1 (de) Glycinsubstituierte thieno(2,3-d)pyrimidine mit kombinierter lh- und fsh-agonistischer wirkung
HUP0303005A3 (en) Pharmaceutical compositions comprising pyrazolo[4,3-d]pyrimidines or thienopyrimidines and endothelin receptor antagonists
NO20040990L (no) Andvendelse av LH i kontrollert ovariehyperstimulering.
ATE276260T1 (de) 2-aminoalkyl-thieno(2,3-d)pyrimidine
DE50106542D1 (de) Substituierte 3,4-dihydro-pyrido[1,2-a]pyrimidine
AU2002305292A1 (en) Novel 4-amino-5,6-substituted thiopheno(2,3-d)pyrimidines
DK1326866T3 (da) Substituerede 3,4-dihydro-pyrido[1,2-a]pyrimidiner
DK1325010T3 (da) Substituerede 3,4-dihydro-pyrimido[1,2-a]pyrimidiner og 3,4-dihydro-pyrazino[1,2-a]pyrimidiner

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1427733

Country of ref document: EP

REN Ceased due to non-payment of the annual fee